Abstract
Summary1. A series of substituted ethylene glycols has been studied for anticonvulsant activity by both the maximal electroshock seizure and subcutaneous Metrazol seizure tests. 2. Fully substituted ethylene glycols are more potent anticonvulsant agents than mono-, di-, or trisubstituted analogues. 2-p-Chlorophenyl − 3 - methyl-2, 3-butanediol (phenaglycodol) has been selected for clinical trial since it has high potency and long duration of action. It is suggested that the long duration of action may be related to full substitution of the ethylene glycol nucleus which should reduce the probability of oxidative detoxification.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
More From: Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.)
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.